In the U.S., we are not seeing any specific localized disruption yet, although I’m watching New Jersey where it could be on the cusp. There are a lot of manufacturing facilities there in pharmaceuticals and chemicals, and therefore that’s an area I think we should be paying attention to.
Displaying 10 results for
The impact of COVID-19 has changed the way we conduct business, and now, more than ever, illuminates the need for manufacturers to assess their processes and implement smart manufacturing technology.
The COVID-19 pandemic is causing major upheavals both in people’s lives and in the manufacturing world. One of the main problems that even the most developed nations are facing is a shortage of personal protection equipment (PPE), including masks, glasses, gowns, safety suits, and fans.
What a difference a month makes. In a survey by the Manufacturing Advocacy and Growth Network (MAGNET) in February, only 24 percent of Ohio manufacturers said innovation was a priority.
With automakers turning out ventilators and protective face shields, brewers and distillers bottling hand sanitizer, and garment factories stitching up gowns and masks to fill a yawning gap in personal protective equipment for health care workers, the coronavirus pandemic is shining a million-watt spotlight on the critical role manufacturing plays in society.
In response to a neighboring company’s request for a collaboration, machine tool manufacturer Mazak Corp. provided some much-needed materials and production capacity for the development of a new UV-C LED surface disinfection system.
The COVID-19 crisis caught all of us off guard and interrupted global systems in a way not experienced in recent memory.
CEO Jason Walker and part of his team at Waypoint Robotics had just returned from the Modex 2020 show in Atlanta when the governor of his company’s home state imposed a stay-at-home order because of COVID-19.
UL says the novel coronavirus (COVID-19) has increased cybersecurity problems for manufacturers.
In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.